Add Our CareHub to Your Site Integrate WellSyncs CareHub directly into your website with ease
The FDA has approved oral semaglutide for adults with obesity (BMI 30) or overweight adults (BMI 27) who also have at least one weight-related condition, such as: Type 2 diabetes High blood pressure Dyslipidemia Cardiovascular disease risk Dr
Medical record lacked documentation of General Inpatient (GIP) level of care
They represent a paradigm shift: a therapy that goes far beyond symptom management to tackle the root causes of chronic disease
To discuss medically supervised weight loss options in Stamford, Greenwich, Fairfield County, or throughout Connecticut, call 203-348-8805
This hormone tells your brain you're full, slows stomach emptying, and helps your pancreas release insulin when blood sugar rises